ResBiotic creates pharmaceutical subsidiary

Birmingham firm also raises $4.5M in seed funding and launches first consumer health product

Birmingham-based ResBiotic has created a drug development spin-off, Alveolus Bio, and launched its first consumer health product, resB Lung Support. Together, the parent firm and spin-off are using $4.5 million in seed funding as they work “to transform the respiratory care landscape and chart new frontiers for microbiome science.” The firms’ work is based on…

Thank you for reading!

To continue reading this article you must be registered and logged into this site. If you already have an account please login now, otherwise you can click here to register for new account. Registration is FREE.

Login       Register

The latest Alabama business news delivered to your inbox